Global Bispecific Antibody Therapeutic Market Research Report 2022 - Market Size, Current Insights and Development Trends

Publisher Name :
Date: 29-Sep-2022
No. of pages: 108

The report focuses on the Bispecific Antibody Therapeutic market size, segment size (mainly covering product type, application, and geography), competitor landscape, recent status, and development trends. Furthermore, the report provides strategies for companies to overcome threats posed by COVID-19.

Technological innovation and advancement will further optimize the performance of the product, enabling it to acquire a wider range of applications in the downstream market. Moreover, customer preference analysis, market dynamics (drivers, restraints, opportunities), new product release, impact of COVID-19, regional conflicts and carbon neutrality provide crucial information for us to take a deep dive into the Bispecific Antibody Therapeutic market.

Major Players in the Bispecific Antibody Therapeutic market are:

Dana-Farber Cancer Institute

Catalent Biologics

CELLSCRIPT

F-star

Fusion Antibodies

Cancer Research UK

Fuda Cancer Hospital

Eli Lilly

EMD Serono

AbCellera

Celgene

Bristol-Myers Squibb

GEMoaB

Calico

Genedata

FZata

FUJIFILM Diosynth Biotechnologies

Ab Studio

AbClon

AbbVie

DCPrime

On the basis of types, the Bispecific Antibody Therapeutic market is primarily split into:

Intravenous

Subcutaneous

Others

On the basis of applications, the market covers:

Hospital Pharmacy

Online Pharmacy

Retail Pharmacy

Major Regions or countries covered in this report:

United States

Europe

China

Japan

India

Southeast Asia

Latin America

Middle East and Africa

Others

Years considered for this report:

Historical Years: 2017-2021

Base Year: 2021

Estimated Year: 2022

Forecast Period: 2022-2029

Global Bispecific Antibody Therapeutic Market Research Report 2022 - Market Size, Current Insights and Development Trends

Table of Content

1 Bispecific Antibody Therapeutic Market Overview
1.1 Product Overview and Scope of Bispecific Antibody Therapeutic Market
1.2 Bispecific Antibody Therapeutic Market Segment by Type
1.2.1 Global Bispecific Antibody Therapeutic Market Sales and CAGR (%) Comparison by Type (2017-2029)
1.3 Global Bispecific Antibody Therapeutic Market Segment by Application
1.3.1 Bispecific Antibody Therapeutic Market Consumption (Sales) Comparison by Application (2017-2029)
1.4 Global Bispecific Antibody Therapeutic Market, Region Wise (2017-2029)
1.5 Global Market Size (Revenue) of Bispecific Antibody Therapeutic (2017-2029)
1.5.1 Global Bispecific Antibody Therapeutic Market Revenue Status and Outlook (2017-2029)
1.5.2 Global Bispecific Antibody Therapeutic Market Sales Status and Outlook (2017-2029)
1.6 Influence of Regional Conflicts on the Bispecific Antibody Therapeutic Industry
1.7 Impact of Carbon Neutrality on the Bispecific Antibody Therapeutic Industry

2 Bispecific Antibody Therapeutic Market Upstream and Downstream Analysis
2.1 Bispecific Antibody Therapeutic Industrial Chain Analysis
2.2 Key Raw Materials Suppliers and Price Analysis
2.3 Key Raw Materials Supply and Demand Analysis
2.4 Market Concentration Rate of Raw Materials
2.5 Manufacturing Process Analysis
2.6 Manufacturing Cost Structure Analysis
2.6.1 Labor Cost Analysis
2.6.2 Energy Costs Analysis
2.6.3 R&D Costs Analysis
2.7 Major Downstream Buyers of Bispecific Antibody Therapeutic Analysis
2.8 Impact of COVID-19 on the Industry Upstream and Downstream

3 Players Profiles
3.1 Dana-Farber Cancer Institute
3.1.1 Dana-Farber Cancer Institute Basic Information, Manufacturing Base, Sales Area and Competitors
3.1.2 Product Profiles, Application and Specification
3.1.3 Bispecific Antibody Therapeutic Market Performance (2017-2022)
3.1.4 Business Overview
3.2 Catalent Biologics
3.2.1 Catalent Biologics Basic Information, Manufacturing Base, Sales Area and Competitors
3.2.2 Product Profiles, Application and Specification
3.2.3 Bispecific Antibody Therapeutic Market Performance (2017-2022)
3.2.4 Business Overview
3.3 CELLSCRIPT
3.3.1 CELLSCRIPT Basic Information, Manufacturing Base, Sales Area and Competitors
3.3.2 Product Profiles, Application and Specification
3.3.3 Bispecific Antibody Therapeutic Market Performance (2017-2022)
3.3.4 Business Overview
3.4 F-star
3.4.1 F-star Basic Information, Manufacturing Base, Sales Area and Competitors
3.4.2 Product Profiles, Application and Specification
3.4.3 Bispecific Antibody Therapeutic Market Performance (2017-2022)
3.4.4 Business Overview
3.5 Fusion Antibodies
3.5.1 Fusion Antibodies Basic Information, Manufacturing Base, Sales Area and Competitors
3.5.2 Product Profiles, Application and Specification
3.5.3 Bispecific Antibody Therapeutic Market Performance (2017-2022)
3.5.4 Business Overview
3.6 Cancer Research UK
3.6.1 Cancer Research UK Basic Information, Manufacturing Base, Sales Area and Competitors
3.6.2 Product Profiles, Application and Specification
3.6.3 Bispecific Antibody Therapeutic Market Performance (2017-2022)
3.6.4 Business Overview
3.7 Fuda Cancer Hospital
3.7.1 Fuda Cancer Hospital Basic Information, Manufacturing Base, Sales Area and Competitors
3.7.2 Product Profiles, Application and Specification
3.7.3 Bispecific Antibody Therapeutic Market Performance (2017-2022)
3.7.4 Business Overview
3.8 Eli Lilly
3.8.1 Eli Lilly Basic Information, Manufacturing Base, Sales Area and Competitors
3.8.2 Product Profiles, Application and Specification
3.8.3 Bispecific Antibody Therapeutic Market Performance (2017-2022)
3.8.4 Business Overview
3.9 EMD Serono
3.9.1 EMD Serono Basic Information, Manufacturing Base, Sales Area and Competitors
3.9.2 Product Profiles, Application and Specification
3.9.3 Bispecific Antibody Therapeutic Market Performance (2017-2022)
3.9.4 Business Overview
3.10 AbCellera
3.10.1 AbCellera Basic Information, Manufacturing Base, Sales Area and Competitors
3.10.2 Product Profiles, Application and Specification
3.10.3 Bispecific Antibody Therapeutic Market Performance (2017-2022)
3.10.4 Business Overview
3.11 Celgene
3.11.1 Celgene Basic Information, Manufacturing Base, Sales Area and Competitors
3.11.2 Product Profiles, Application and Specification
3.11.3 Bispecific Antibody Therapeutic Market Performance (2017-2022)
3.11.4 Business Overview
3.12 Bristol-Myers Squibb
3.12.1 Bristol-Myers Squibb Basic Information, Manufacturing Base, Sales Area and Competitors
3.12.2 Product Profiles, Application and Specification
3.12.3 Bispecific Antibody Therapeutic Market Performance (2017-2022)
3.12.4 Business Overview
3.13 GEMoaB
3.13.1 GEMoaB Basic Information, Manufacturing Base, Sales Area and Competitors
3.13.2 Product Profiles, Application and Specification
3.13.3 Bispecific Antibody Therapeutic Market Performance (2017-2022)
3.13.4 Business Overview
3.14 Calico
3.14.1 Calico Basic Information, Manufacturing Base, Sales Area and Competitors
3.14.2 Product Profiles, Application and Specification
3.14.3 Bispecific Antibody Therapeutic Market Performance (2017-2022)
3.14.4 Business Overview
3.15 Genedata
3.15.1 Genedata Basic Information, Manufacturing Base, Sales Area and Competitors
3.15.2 Product Profiles, Application and Specification
3.15.3 Bispecific Antibody Therapeutic Market Performance (2017-2022)
3.15.4 Business Overview
3.16 FZata
3.16.1 FZata Basic Information, Manufacturing Base, Sales Area and Competitors
3.16.2 Product Profiles, Application and Specification
3.16.3 Bispecific Antibody Therapeutic Market Performance (2017-2022)
3.16.4 Business Overview
3.17 FUJIFILM Diosynth Biotechnologies
3.17.1 FUJIFILM Diosynth Biotechnologies Basic Information, Manufacturing Base, Sales Area and Competitors
3.17.2 Product Profiles, Application and Specification
3.17.3 Bispecific Antibody Therapeutic Market Performance (2017-2022)
3.17.4 Business Overview
3.18 Ab Studio
3.18.1 Ab Studio Basic Information, Manufacturing Base, Sales Area and Competitors
3.18.2 Product Profiles, Application and Specification
3.18.3 Bispecific Antibody Therapeutic Market Performance (2017-2022)
3.18.4 Business Overview
3.19 AbClon
3.19.1 AbClon Basic Information, Manufacturing Base, Sales Area and Competitors
3.19.2 Product Profiles, Application and Specification
3.19.3 Bispecific Antibody Therapeutic Market Performance (2017-2022)
3.19.4 Business Overview
3.20 AbbVie
3.20.1 AbbVie Basic Information, Manufacturing Base, Sales Area and Competitors
3.20.2 Product Profiles, Application and Specification
3.20.3 Bispecific Antibody Therapeutic Market Performance (2017-2022)
3.20.4 Business Overview
3.21 DCPrime
3.21.1 DCPrime Basic Information, Manufacturing Base, Sales Area and Competitors
3.21.2 Product Profiles, Application and Specification
3.21.3 Bispecific Antibody Therapeutic Market Performance (2017-2022)
3.21.4 Business Overview

4 Global Bispecific Antibody Therapeutic Market Landscape by Player
4.1 Global Bispecific Antibody Therapeutic Sales and Share by Player (2017-2022)
4.2 Global Bispecific Antibody Therapeutic Revenue and Market Share by Player (2017-2022)
4.3 Global Bispecific Antibody Therapeutic Average Price by Player (2017-2022)
4.4 Global Bispecific Antibody Therapeutic Gross Margin by Player (2017-2022)
4.5 Bispecific Antibody Therapeutic Market Competitive Situation and Trends
4.5.1 Bispecific Antibody Therapeutic Market Concentration Rate
4.5.2 Bispecific Antibody Therapeutic Market Share of Top 3 and Top 6 Players
4.5.3 Mergers & Acquisitions, Expansion

5 Global Bispecific Antibody Therapeutic Sales, Revenue, Price Trend by Type
5.1 Global Bispecific Antibody Therapeutic Sales and Market Share by Type (2017-2022)
5.2 Global Bispecific Antibody Therapeutic Revenue and Market Share by Type (2017-2022)
5.3 Global Bispecific Antibody Therapeutic Price by Type (2017-2022)
5.4 Global Bispecific Antibody Therapeutic Sales, Revenue and Growth Rate by Type (2017-2022)
5.4.1 Global Bispecific Antibody Therapeutic Sales, Revenue and Growth Rate of Intravenous (2017-2022)
5.4.2 Global Bispecific Antibody Therapeutic Sales, Revenue and Growth Rate of Subcutaneous (2017-2022)
5.4.3 Global Bispecific Antibody Therapeutic Sales, Revenue and Growth Rate of Others (2017-2022)

6 Global Bispecific Antibody Therapeutic Market Analysis by Application
6.1 Global Bispecific Antibody Therapeutic Consumption and Market Share by Application (2017-2022)
6.2 Global Bispecific Antibody Therapeutic Consumption Revenue and Market Share by Application (2017-2022)
6.3 Global Bispecific Antibody Therapeutic Consumption and Growth Rate by Application (2017-2022)
6.3.1 Global Bispecific Antibody Therapeutic Consumption and Growth Rate of Hospital Pharmacy (2017-2022)
6.3.2 Global Bispecific Antibody Therapeutic Consumption and Growth Rate of Online Pharmacy (2017-2022)
6.3.3 Global Bispecific Antibody Therapeutic Consumption and Growth Rate of Retail Pharmacy (2017-2022)

7 Global Bispecific Antibody Therapeutic Sales and Revenue Region Wise (2017-2022)
7.1 Global Bispecific Antibody Therapeutic Sales and Market Share, Region Wise (2017-2022)
7.2 Global Bispecific Antibody Therapeutic Revenue and Market Share, Region Wise (2017-2022)
7.3 Global Bispecific Antibody Therapeutic Sales, Revenue, Price and Gross Margin (2017-2022)
7.4 United States Bispecific Antibody Therapeutic Sales, Revenue, Price and Gross Margin (2017-2022)
7.5 Europe Bispecific Antibody Therapeutic Sales, Revenue, Price and Gross Margin (2017-2022)
7.6 China Bispecific Antibody Therapeutic Sales, Revenue, Price and Gross Margin (2017-2022)
7.7 Japan Bispecific Antibody Therapeutic Sales, Revenue, Price and Gross Margin (2017-2022)
7.8 India Bispecific Antibody Therapeutic Sales, Revenue, Price and Gross Margin (2017-2022)
7.9 Southeast Asia Bispecific Antibody Therapeutic Sales, Revenue, Price and Gross Margin (2017-2022)
7.10 Latin America Bispecific Antibody Therapeutic Sales, Revenue, Price and Gross Margin (2017-2022)
7.11 Middle East and Africa Bispecific Antibody Therapeutic Sales, Revenue, Price and Gross Margin (2017-2022)

8 Global Bispecific Antibody Therapeutic Market Forecast (2022-2029)
8.1 Global Bispecific Antibody Therapeutic Sales, Revenue Forecast (2022-2029)
8.1.1 Global Bispecific Antibody Therapeutic Sales and Growth Rate Forecast (2022-2029)
8.1.2 Global Bispecific Antibody Therapeutic Revenue and Growth Rate Forecast (2022-2029)
8.1.3 Global Bispecific Antibody Therapeutic Price and Trend Forecast (2022-2029)
8.2 Global Bispecific Antibody Therapeutic Sales and Revenue Forecast, Region Wise (2022-2029)
8.2.1 United States Bispecific Antibody Therapeutic Sales and Revenue Forecast (2022-2029)
8.2.2 Europe Bispecific Antibody Therapeutic Sales and Revenue Forecast (2022-2029)
8.2.3 China Bispecific Antibody Therapeutic Sales and Revenue Forecast (2022-2029)
8.2.4 Japan Bispecific Antibody Therapeutic Sales and Revenue Forecast (2022-2029)
8.2.5 India Bispecific Antibody Therapeutic Sales and Revenue Forecast (2022-2029)
8.2.6 Southeast Asia Bispecific Antibody Therapeutic Sales and Revenue Forecast (2022-2029)
8.2.7 Latin America Bispecific Antibody Therapeutic Sales and Revenue Forecast (2022-2029)
8.2.8 Middle East and Africa Bispecific Antibody Therapeutic Sales and Revenue Forecast (2022-2029)
8.3 Global Bispecific Antibody Therapeutic Sales, Revenue and Price Forecast by Type (2022-2029)
8.3.1 Global Bispecific Antibody Therapeutic Revenue and Growth Rate of Intravenous (2022-2029)
8.3.2 Global Bispecific Antibody Therapeutic Revenue and Growth Rate of Subcutaneous (2022-2029)
8.3.3 Global Bispecific Antibody Therapeutic Revenue and Growth Rate of Others (2022-2029)
8.4 Global Bispecific Antibody Therapeutic Consumption Forecast by Application (2022-2029)
8.4.1 Global Bispecific Antibody Therapeutic Consumption Value and Growth Rate of Hospital Pharmacy (2022-2029)
8.4.2 Global Bispecific Antibody Therapeutic Consumption Value and Growth Rate of Online Pharmacy (2022-2029)
8.4.3 Global Bispecific Antibody Therapeutic Consumption Value and Growth Rate of Retail Pharmacy (2022-2029)
8.5 Bispecific Antibody Therapeutic Market Forecast Under COVID-19

9 Industry Outlook
9.1 Bispecific Antibody Therapeutic Market Drivers Analysis
9.2 Bispecific Antibody Therapeutic Market Restraints and Challenges
9.3 Bispecific Antibody Therapeutic Market Opportunities Analysis
9.4 Emerging Market Trends
9.5 Bispecific Antibody Therapeutic Industry Technology Status and Trends
9.6 News of Product Release
9.7 Consumer Preference Analysis
9.8 Bispecific Antibody Therapeutic Industry Development Trends under COVID-19 Outbreak
9.8.1 Global COVID-19 Status Overview
9.8.2 Influence of COVID-19 Outbreak on Bispecific Antibody Therapeutic Industry Development

10 Research Findings and Conclusion

11 Appendix
11.1 Methodology
11.2 Research Data Source
  • Global Antibody Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 136
    According to our LPI (LP Information) latest study, the global Antibody market size was valued at US$ 8893.3 million in 2023. With growing demand in downstream market, the Antibody is forecast to a readjusted size of US$ 12940 million by 2030 with a CAGR of 5.5% during review period. The research report highlights the growth potential of the global Antibody market. Antibody are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supp......
  • Global Antibody Production Market Status and Outlook 2023-2028
    Published: 22-Dec-2023        Price: US 3160 Onwards        Pages: 121
    Antibody production involves preparation of antigen samples and their safe injection into laboratory or farm animals so as to evoke high expression levels of antigen-specific antibodies in the serum, which can then be recovered from the animal. Polyclonal antibodies are recovered directly from serum (bleeds). Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (mil......
  • Global Antibody Production Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
    Published: 21-Dec-2023        Price: US 3380 Onwards        Pages: 100
    Market Overview of Global Antibody Production market: According to our latest research, the global Antibody Production market looks promising in the next 5 years. As of 2022, the global Antibody Production market was estimated at USD 9193.37 million, and it's anticipated to reach USD 17140.24 million in 2028, with a CAGR of 10.94% during the forecast years. This report covers a research time span from 2018 to 2028, and presents a deep and comprehensive analysis of the global ......
  • Global Antibody Production Market Research Report 2024 (Status and Outlook)
    Published: 15-Dec-2023        Price: US 3200 Onwards        Pages: 117
    Report Overview: The Global Antibody Production Market Size was estimated at USD 8847.90 million in 2022 and is projected to reach USD 14207.79 million by 2029, exhibiting a CAGR of 7.00% during the forecast period. This report provides a deep insight into the global Antibody Production market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key mark......
  • Global Anti-CD20 Monoclonal Antibodies Professional Survey Report 2023, Forecast to 2028
    Published: 30-Nov-2023        Price: US 3280 Onwards        Pages: 100
    Anti-CD20 monoclonal antibodies (mAbs) are used to achieve B cell depletion, and were initially developed to treat B cell proliferative disorders, including non-Hodgkin's lymphoma (NHL) and chronic lymphocytic leukemia (CLL). Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each segment and sub-segment. This way, clients can achieve all th......
  • Global Anti-CD20 Monoclonal Antibodies Market Research Report 2023, Forecast to 2028
    Published: 30-Nov-2023        Price: US 2680 Onwards        Pages: 165
    Anti-CD20 monoclonal antibodies (mAbs) are used to achieve B cell depletion, and were initially developed to treat B cell proliferative disorders, including non-Hodgkin's lymphoma (NHL) and chronic lymphocytic leukemia (CLL). Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each segment and sub-segment. This way, clients can achieve all th......
  • Monoclonal Antibody Industry Forecasts - China Focus
    Published: 27-Nov-2023        Price: US 1800 Onwards        Pages: 92
    This study focuses on China's Monoclonal Antibody industry forecasts. In the two past decades, the industry has been growing at a fast pace. The dramatic expansions of the manufacturing capabilities and rising consumer consumptions in China have transformed China's society and economy. China is one of the world's major producers for industrial and consumer products. Far outpacing other economies in the world, China is the world's fastest growing market for the consumptions of goods and services.......
  • Monoclonal Antibody Companies in China
    Published: 27-Nov-2023        Price: US 1800 Onwards        Pages: 73
    This study focuses on China's Monoclonal Antibody industry assessments and company profiles. In the two past decades, the industry has been growing at a fast pace. The dramatic expansions of the manufacturing capabilities and rising consumer consumptions in China have transformed China's society and economy. China is one of the world's major producers for industrial and consumer products. Far outpacing other economies in the world, China is the world's fastest growing market for the consumptions......
  • Monoclonal Antibody Markets in China
    Published: 27-Nov-2023        Price: US 4000 Onwards        Pages: 219
    China's demand for Monoclonal Antibody has grown at a fast pace in the past decade. In the next decade, both production and demand will continue to grow. The Chinese economy maintains a high speed growth which has been stimulated by the consecutive increases of industrial output, imports & exports, consumer consumption and capital investment for over two decades. This new study examines China's economic trends, investment environment, industry development, supply and demand, industry capacity, i......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs